Sepracor Inc. (NASDAQ:SEPR) of Marlborough, Mass., andSterling Winthrop Inc. of New York have entered into a jointagreement to develop for over-the-counter use and to marketan analgesic product based on a single isomer form of a currentnon-steroidal, anti-inflammatory prescription drug. Specificterms of the agreement were not disclosed.

(c) 1997 American Health Consultants. All rights reserved.

No Comments